Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOn day 1 of Wegovy, most people inject their first 0.25 mg dose and feel very little — perhaps mild nausea later in the day, or nothing at all. That is deliberate. The starter dose is designed to let your body adjust, not to produce dramatic results on the first try. Wegovy is a prescription-only medicine containing semaglutide, a GLP-1 receptor agonist licensed in the UK for weight management in adults. A clinical assessment by a prescriber is required before treatment can begin — learn more about Wegovy on the treatment overview page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before day 1 on Wegovy even starts, a few practical steps reduce the chance of preventable discomfort. Take your pen out of the fridge roughly 30 minutes before injecting; a cold injection can sting more than a room-temperature one. Clean the chosen site with an alcohol swab and let it dry. Pick one of the three licensed sites (abdomen (at least 5 cm from the navel), front of the thigh, or outer upper arm) and commit to rotating that site each week to avoid irritation building up.
Food timing matters from the beginning. Many people find that injecting after a light meal, rather than on an empty stomach, takes the edge off early nausea. There is no clinical rule requiring a fasted state for the injection itself, unlike the oral semaglutide tablet, so give yourself whatever practical window works. If you tend to inject on a Monday morning, the day-1 ritual slots in easily; if your prescription arrives mid-week because you ordered near a bank holiday, that timing becomes your new weekly anchor.
Check the pen's inspection window before use. The liquid should be clear and colourless. If it is cloudy, discoloured, or contains particles, do not use it, contact your prescriber or pharmacy. The semaglutide overview page covers the full device instructions and licensed strengths.
The Wegovy pre-filled pen is designed to be used without clinical training. Press the pen firmly against the cleaned skin, unlock the safety, and press the button until you hear a click, then hold for several seconds to make sure the full dose delivers. Most people describe the sensation as a mild pinch. Genuine discomfort is unusual at the 0.25 mg starter dose.
Needle disposal matters from the first use. Used pens contain a needle that must go into a sharps container, not a household bin. A one-litre sharps container handles a full titration course and beyond.
Note the date in your phone or diary. Your next injection is exactly seven days later. Consistency around the same day each week helps, though the NHS guidance allows a one-to-two-day flexibility window if something unavoidable shifts your schedule, defer to your prescriber and the Patient Information Leaflet for any specific timing question. The day-by-day Wegovy guide covers what to expect across the full first weeks of treatment.
In the hours after a first Wegovy injection, the most common experience is nothing remarkable. Some people notice mild nausea toward the evening, especially after eating a large or fatty meal. Loose stools, bloating, or a general feeling of fullness can appear. These effects are part of how GLP-1 receptor agonists work (slowing gastric emptying and signalling satiety to the brain) and they are almost always mild at 0.25 mg.
The NHS medicines page for semaglutide lists the most frequently reported side effects as nausea, vomiting, diarrhoea, constipation, and stomach pain, with most being transient and settling as the body adjusts. Staying well hydrated helps, as does eating smaller portions and avoiding high-fat foods on day 1 and the days immediately after. If you are worried about managing loose stools specifically, the interaction between Imodium and Wegovy is covered in detail.
Get urgent medical help if you develop severe stomach pain that spreads to your back, this can be a sign of pancreatitis, a known but uncommon risk with GLP-1 medicines. The MHRA highlighted acute pancreatitis in a January 2026 Drug Safety Update for this class of medicine. Signs of an allergic reaction (swelling of the face, difficulty breathing, rapid heartbeat) also need immediate attention. These are rare; knowing them is simply good practice.
Most people do not feel any different on the appetite front on day 1 itself. Semaglutide builds its effect over weeks of dose escalation. Day 1 is a starting point, not a results checkpoint. For those curious whether the scales might even nudge upward early in treatment, the question of early weight gain on Wegovy has a straightforward explanation worth reading before drawing conclusions.
Day 1 is the first step in a titration schedule that typically runs over several months before reaching the 2.4 mg maintenance dose. Each four-week period at a given dose lets tolerance build before the prescriber considers moving up. The clinical evidence comes from the STEP 1 trial, published in the New England Journal of Medicine, which reported an average weight reduction of around 15% over 68 weeks at the 2.4 mg dose, a figure achieved over time, not overnight.
Understanding what is normal on day 2 and day 3 helps set accurate expectations for the first week, when side effects tend to be most noticeable. Tracking your own pattern (energy, appetite, sleep, GI symptoms) gives useful information to share at your next clinical review. For anyone considering whether Wegovy is the right route, our prescribers are available to answer questions before any decision is made; the treatment page explains how the consultation works. You might also find it useful to compare how the first day differs if you are looking at starting semaglutide more broadly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.